ProstaScint

Drug List

ProstaScint

Drug Name

ProstaScint (Diagnostic imaging agent)

Manufactured By

Jazz Pharmaceuticals, Inc.

Drug Savings

NPC's mission is your health. We recognize your need for help when you are applying for discount programs for your prescription medications. We consist of friendly and experienced advocates that not only know how these free and discount programs work, but are ready to help. We are available to take your call and answer any questions you may have as you search for the right program to fit your needs. We can also explain any supporting material you may need to provide as you apply for these programs. If for any reason you are denied, we also are experienced in the best appeals process with a high success rate.

NPC's mission is your health. We recognize your need for help when you are applying for discount programs for your prescription medications. We consist of friendly and experienced advocates that not only know how these free and discount programs work, but are ready to help. We are available to take your call and answer any questions you may have as you search for the right program to fit your needs. We can also explain any supporting material you may need to provide as you apply for these programs. If for any reason you are denied, we also are experienced in the best appeals process with a high success rate.

Treats Disease/Condition

Uses

ProstaScint is the only commercially available diagnostic imaging agent approved by the FDA that specifically targets prostate cancer cells that have spread to tissue outside of the prostate gland. It consists of a novel murine monoclonal antibody that, when conjugated to a linker-chelator and radiolabeled, binds distinctly to Prostate Specific Membrane Antigen (PSMA). PSMA is a glycoprotein expressed by prostate epithelium, which is up regulated in prostate cancer. PSMA is expressed on metastatic prostate cancer tissue. Combined with a CT or MRI scan, this fusion imaging study helps to determine the location and extent of metastatic lymph node disease. Knowing whether the prostate cancer is confined to the gland or has spread to the lymph nodes helps physicians determine appropriate patient management

How To Use

When ProstaScint® is administered to you; it contains a small amount of radioactive material to make it possible for special cameras to detect it within the body. This small amount of material should not cause you any harm. How the Scan is Done The ProstaScint® scan takes place in 2 parts. On day one you will receive an injection of ProstaScint® over a short period of time. A Nuclear Medicine professional will administer the injection and monitor you during and shortly after the injection. There are usually no unpleasant reactions and other activities do not need to be changed at this time, including eating and drinking. About 96 hours (4 days) after you have received the ProstaScint® injection, you will be asked to come back for your scan. A Nuclear Medicine technologist will position you under a special camera and take a number of different images or pictures. The scanning or imaging process usually takes about two hours.

Side Effects

ProstaScint® is generally well tolerated. Adverse effects have been reported in about 4% of patients. The most common adverse reactions are increased levels of bilirubin in the blood, elevated blood pressure and low blood pressure. These reactions were reported to occur in less than 1% of patients. It is very unlikely that you will experience any symptoms. After a ProstaScint® infusion you will be able to resume your normal daily activities. A ProstaScint® infusion will have no effect on your sexual function

Drug Interactions

In Case of Overdose

In Case of Missed Dose

Storage